Utility of polygenic risk scores in UK cancer screening: a modelling analysis. (2023)
Attributed to:
Multimorbidity Mechanism and Therapeutics Research Collaborative
funded by
SPF
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/s1470-2045(23)00156-0
PubMed Identifier: 37178708
Publication URI: http://europepmc.org/abstract/MED/37178708
Type: Journal Article/Review
Volume: 24
Parent Publication: The Lancet. Oncology
Issue: 6
ISSN: 1470-2045